Skip to main content

Gene editing utilizing CRISPR-Cas is transforming biological research and the development of new bio-based products. The Caribou proprietary technology platform positions us to be at the forefront of advancements in multiple major markets, including: 

  • Therapeutics
  • Agricultural biotechnology
  • Biological research
  • Industrial biotechnology

In addition to our in-house research and engineering resources, we collaborate with recognized industry leaders who help illuminate and guide potential applications of our technology and speed our product development.

About Us

Pioneering the translation of CRISPR-Cas genome engineering into new medical therapies and bio-based products. Learn more. 

CRISPR-Cas Technology

The Caribou CRISPR-Cas technology platform enables simple, flexible targeting of any site in a genome. Learn more. 

Contact Us

For media and investor inquiries and general information, click here.